EXPRESSION OF TYPE-III HYPERLIPOPROTEINEMIA IN A SUBJECT WITH SECONDARY HYPOTHYROIDISM BEARING THE APOLIPOPROTEIN E2/2 PHENOTYPE

被引：11
|
作者：
FEUSSNER, G
ZIEGLER, R
机构：
[1] Department of Internal Medicine I, Endocrinology and Metabolism, University of Heidelberg, Heidelberg
来源：
JOURNAL OF INTERNAL MEDICINE | 1991年 / 230卷 / 02期
关键词：
APOLIPOPROTEIN-E; FAMILIAL DYSBETALIPOPROTEINEMIA; SECONDARY HYPOTHYROIDISM; TYPE-III HYPERLIPOPROTEINEMIA;
D O I：
10.1111/j.1365-2796.1991.tb00428.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Post-surgical hypothyroidism developed in a now 43-year-old woman with complete insufficiency of the anterior pituitary gland who discontinued levothyroxine replacement therapy. Serum cholesterol and serum triglyceride levels increased in parallel, and classical type III hyperlipoproteinaemia (HLP) with xanthoma striata palmaris developed. The patient is homozygous for apolipoprotein (apo) E2. The case reported here represents the first example of manifestation of type III hyperlipoproteinaemia in a subject with secondary hypothyroidism bearing the apo E2/2 phenotype.
引用
收藏
页码：183 / 186
页数：4
相关论文
共 26 条
  • [1] Expression of type III hyperlipoproteinemia in apolipoprotein E2 (Arg158→Cys) homozygotes is associated with hyperinsulinemia
    de Beer, F
    Stalenhoef, AFH
    Hoogerbrugge, N
    Kastelein, JJP
    Leuven, JAG
    van Duijn, CM
    Havekes, LM
    Smelt, AHM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (02) : 294 - 299
  • [2] Genetic factors precipitating type III hyperlipoproteinemia in hypolipidemic transgenic mice expressing human apolipoprotein E2
    Huang, Y
    Rall, SC
    Mahley, RW
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) : 2817 - 2824
  • [3] Type III hyperlipoproteinema with apolipoprotein E2/2 genotype in Japan
    Eto, M
    Saito, M
    Nakata, H
    Iwashima, Y
    Watanabe, K
    Ikoda, A
    Kaku, K
    CLINICAL GENETICS, 2002, 61 (06) : 416 - 422
  • [4] SEVERE TYPE-III HYPERLIPOPROTEINEMIA ASSOCIATED WITH UNUSUAL APOLIPOPROTEIN-E1 PHENOTYPE AND EPSILON-1 NULL GENOTYPE
    FEUSSNER, G
    FUNKE, H
    WENG, W
    ASSMANN, G
    LACKNER, KJ
    ZIEGLER, R
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1992, 22 (09) : 599 - 608
  • [5] Protease inhibitor related type III hyperlipoproteinaemia is common and not associated with apolipoprotein-E E2/E2 phenotype
    Shahmanesh, M
    Jaleel, H
    DeSilva, Y
    Ross, JDC
    Caslake, M
    Cramb, R
    SEXUALLY TRANSMITTED INFECTIONS, 2001, 77 (04) : 283 - 286
  • [6] A novel apolipoprotein E2 variant, E2Toranomon(Q187E), identified in a type III hyperlipoproteinemia patient with coronary atherosclerosis
    Okubo, M
    Aoyama, Y
    Harada, K
    Fukawa, M
    Tsukada, T
    Mokuno, H
    Yamada, N
    Murase, T
    ATHEROSCLEROSIS, 1998, 140 (01) : 187 - 190
  • [7] The apolipoprotein E2 (Arg145Cys) mutation causes autosomal dominant type III hyperlipoproteinemia with incomplete penetrance
    deVilliers, WJS
    vanderWesthuyzen, DR
    Coetzee, GA
    Henderson, HE
    Marais, AD
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (05) : 865 - 872
  • [8] SEVERE TYPE-III HYPERLIPOPROTEINEMIA IN 2 PATIENTS MAINTAINED ON CHRONIC-HEMODIALYSIS
    FEUSSNER, G
    BOMMER, J
    ZIEGLER, R
    KLINISCHE WOCHENSCHRIFT, 1990, 68 (02): : 65 - 70
  • [9] APOLIPOPROTEIN E1 LYS-146-]GLU WITH TYPE-III HYPERLIPOPROTEINEMIA
    MORIYAMA, K
    SASAKI, J
    MATSUNAGA, A
    ARAKAWA, F
    TAKADA, Y
    ARAKI, K
    KANEKO, S
    ARAKAWA, K
    BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1128 (01) : 58 - 64
  • [10] Apolipoprotein ε2/3 genotype and type III hyperlipoproteinemia among Taiwanese
    Lin, HP
    Kao, JT
    CLINICA CHIMICA ACTA, 2003, 330 (1-2) : 173 - 178
123